Lv5
1196 积分 2020-08-09 加入
Trial of Anti-BDCA2 Antibody Litifilimab for Cutaneous Lupus Erythematosus
2天前
已完结
Trial of Anti-BDCA2 Antibody Litifilimab for Cutaneous Lupus Erythematosus
2天前
已完结
Analytical Development and Testing Strategy of Antibody–Drug Conjugates
6天前
已完结
How to build anti-PD1 agonist antibodies
8天前
已完结
Navigating the landscape of EGFR TKI resistance in EGFR-mutant NSCLC — mechanisms and evolving treatment approaches
9天前
已完结
Advances in the management of metastatic gastric cancer: current strategies and emerging therapeutics
21天前
已完结
China’s innovation in translational medicine: rethinking early-stage clinical development
2个月前
已完结
In vivo CAR-Ts captivate big pharma
2个月前
已完结
Mapping the science–technology translational landscape in biomedicine
2个月前
已完结
Biopharma dealmaking in 2025
2个月前
已完结
皖公网安备34019202002308
